Register Login

EMBECTA CORP. (EMBC)

SymbolEMBC
NameEMBECTA CORP.
SectorHEALTH CARE
RegionNorth America
IndustryMedical/Dental Instruments
Address300 KIMBALL DRIVE,SUITE 300, PARSIPPANY, New Jersey, 07054, United States
Telephone+1 862 - 401-0000
Fax—
Email—
Websitehttps://www.embecta.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001872789
Description

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Additional info from NASDAQ:
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

2026-05-08 13:00

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

Read more
2026-05-05 16:56

New Form SCHEDULE 13G - Embecta Corp. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0000897069-26-001012 <b>Size:</b> 17 KB

Read more
2026-05-05 10:55

(75% Positive) EMBECTA CORP. (EMBC) Reports Q2 2026 Financial Results

Read more
2026-05-05 10:30

embecta Announces Quarterly Cash Dividend

Read more
2026-05-05 10:30

Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

Read more
2026-05-01 11:09

New Form SCHEDULE 13G/A - Embecta Corp. <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0000052388-26-000100 <b>Size:</b> 14 KB

Read more
2026-04-29 19:13

New Form SCHEDULE 13G - Embecta Corp. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0002100119-26-000401 <b>Size:</b> 7 KB

Read more
2026-04-21 21:00

embecta to Report Fiscal Second Quarter Financial Results

Read more
2026-03-26 19:03

New Form SCHEDULE 13G/A - Embecta Corp. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-001103 <b>Size:</b> 7 KB

Read more
2026-03-19 10:30

embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT06692153 Embecta AID System in Adults With Type 2 Diabetes Na Type 2 Diabetes Withdrawn 2025-01-01 2026-05-01 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Standard of Care (SC) Other Approved Type 2 Diabetes WITHDRAWN NCT06692153
An AID System. Other Approved Type 2 Diabetes WITHDRAWN NCT06692153
Standard of Care (SC) OTHER Approved Type 2 Diabetes WITHDRAWN NCT06692153
An AID System. DEVICE Approved Type 2 Diabetes WITHDRAWN NCT06692153
Total products: 4